Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117370603 | 11737060 | 3 | F | 1988 | 20160627 | 20151113 | 20160705 | EXP | US-ASTRAZENECA-2012SE74505 | ASTRAZENECA | 51.00 | YR | F | Y | 86.20000 | KG | 20160705 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117370603 | 11737060 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | TABLET | ||||||||
| 117370603 | 11737060 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | 10 | MG | TABLET | QD | |||||
| 117370603 | 11737060 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 4 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 7 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 8 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 10 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 11 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 12 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 0 | ||||||||||||
| 117370603 | 11737060 | 13 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | 0 | TABLET | |||||||||||
| 117370603 | 11737060 | 14 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 25.0MG UNKNOWN | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117370603 | 11737060 | 1 | Blood cholesterol increased |
| 117370603 | 11737060 | 2 | Blood cholesterol increased |
| 117370603 | 11737060 | 4 | Arrhythmia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117370603 | 11737060 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117370603 | 11737060 | Angina pectoris | |
| 117370603 | 11737060 | Arrhythmia | |
| 117370603 | 11737060 | Blood triglycerides increased | |
| 117370603 | 11737060 | Breast cancer | |
| 117370603 | 11737060 | Cardiovascular disorder | |
| 117370603 | 11737060 | Coronary artery disease | |
| 117370603 | 11737060 | Gestational diabetes | |
| 117370603 | 11737060 | Hypertension | |
| 117370603 | 11737060 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117370603 | 11737060 | 1 | 1988 | 0 | ||
| 117370603 | 11737060 | 2 | 20101202 | 0 | ||
| 117370603 | 11737060 | 3 | 201207 | 0 | ||
| 117370603 | 11737060 | 5 | 1988 | 0 | ||
| 117370603 | 11737060 | 6 | 1988 | 0 | ||
| 117370603 | 11737060 | 7 | 1988 | 0 | ||
| 117370603 | 11737060 | 8 | 1988 | 0 | ||
| 117370603 | 11737060 | 9 | 1988 | 0 | ||
| 117370603 | 11737060 | 10 | 1988 | 0 | ||
| 117370603 | 11737060 | 11 | 1988 | 0 | ||
| 117370603 | 11737060 | 12 | 201004 | 201012 | 0 |